DEFA14A: Patterson Companies to be Acquired by Patient Square Capital for $4.1 Billion

Patterson Companies has agreed to be acquired by Patient Square Capital in a deal valued at approximately $4.1 billion, including the refinancing of receivables facilities.

Summary

• Patterson Companies has entered into an agreement to be acquired by Patient Square Capital, a healthcare investment firm.
• The transaction is valued at approximately $4.1 billion, which includes the refinancing of Patterson's receivables facilities.
• The acquisition price is $31.35 per share.
• Upon completion of the transaction, Patterson will become a private company.
• The company will continue to operate as a publicly traded company until the transaction is finalized.
• An all-employee meeting was scheduled to address questions regarding the acquisition.

Sentiment

Score: 7

Explanation: The document conveys a positive outlook regarding the acquisition, emphasizing the benefits for stakeholders, but also acknowledges the inherent risks associated with the transaction.

Positives

• The acquisition by Patient Square Capital is expected to bring positive benefits to Patterson, its employees, and customers.
• Patient Square Capital is a dedicated healthcare investment firm with a focus on growth-oriented companies.
• The transaction provides a clear valuation of $31.35 per share for shareholders.

Negatives

• Patterson will no longer be a publicly traded company after the acquisition is complete.
• The document outlines several risks associated with the merger, including the possibility of it not being completed.

Risks

• The merger may not be completed within the anticipated timeframe or at all.
• Failure to obtain necessary regulatory or shareholder approvals could prevent the merger.
• The merger could disrupt current plans and operations.
• There is a risk of losing key personnel and customer relationships.
• The stock price may decline if the merger is not completed.
• Legal proceedings related to the merger could arise.
• The company is dependent on suppliers and faces risks related to product obsolescence and innovation.
• Cybersecurity attacks and risks associated with AI systems are also noted.
• The company faces risks related to the highly competitive dental and animal health supply markets.
• There are risks associated with the health care industry, including changes in demand due to political, economic and regulatory influences.
• The company faces risks related to litigation and government inquiries and investigations.
• Failure to comply with health care fraud or other laws and regulations is a risk.
• There are risks inherent in international operations, including currency fluctuations.
• Uncertain macro-economic conditions, including inflationary pressures, pose a risk.

Future Outlook

The document states that Patterson will become a private company upon completion of the transaction, and the company is optimistic about the future prospects under the new ownership.

Management Comments

• Don Zurbay, President & CEO, expressed excitement about the next phase of Patterson's journey.
• Management believes the transaction will have positive benefits for Patterson, its employees, and customers.
• Management encourages employees to remain focused on their day-to-day responsibilities.

Industry Context

The acquisition reflects a trend of private equity firms investing in healthcare companies, seeking to leverage their expertise and resources to drive growth and improve patient outcomes. This is a significant transaction in the dental and animal health supply markets.

Comparison to Industry Standards

• The acquisition of Patterson Companies by Patient Square Capital is a significant transaction in the healthcare distribution sector, comparable to other private equity acquisitions of similar-sized companies.
• The valuation of $4.1 billion reflects a premium over the current market capitalization, which is typical in such transactions.
• Comparable companies in the dental and animal health supply markets include Henry Schein and MWI Animal Health, which have also seen significant M&A activity in recent years.

Stakeholder Impact

• Shareholders will receive $31.35 per share upon completion of the acquisition.
• Employees are encouraged to remain focused on their responsibilities during the transition.
• Customers are expected to benefit from the partnership with Patient Square Capital.
• The company believes the transaction will have positive benefits for all stakeholders.

Next Steps

• A special meeting of shareholders will be announced to seek approval for the merger.
• Patterson will file a proxy statement and other relevant documents with the SEC.
• The company will continue to operate as a publicly traded company until the transaction is finalized.

Key Dates

Keywords

acquisition, merger, private company, Patient Square Capital, healthcare investment, Patterson Companies, shareholders, transaction, dental, animal health